Hofseth BioCare ASA (OSL:HBC)
Norway
· Delayed Price · Currency is NOK 2.110
+0.020 (0.96%)
Mar 14, 2025, 11:16 AM CET
Hofseth BioCare ASA Cash Flow Statement
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | -123.41 | -106.68 | -137.39 | -126.46 | -102.09 | Upgrade
|
| Depreciation & Amortization | 39.78 | 29.87 | 24.41 | 25.72 | 23.36 | Upgrade
|
| Other Amortization | - | 6.54 | 5.81 | 3.63 | 3.41 | Upgrade
|
| Loss (Gain) From Sale of Assets | -8.12 | -23.49 | - | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | 0.19 | - | - | Upgrade
|
| Loss (Gain) on Equity Investments | 138.41 | 2.54 | -0.2 | -0.03 | 0.78 | Upgrade
|
| Other Operating Activities | 15.68 | 9.49 | 9.95 | 9.39 | 8.66 | Upgrade
|
| Change in Accounts Receivable | -4 | -0.78 | -3.98 | 4.18 | -8.73 | Upgrade
|
| Change in Inventory | 26.63 | 33.98 | -25.71 | -17.51 | -39.32 | Upgrade
|
| Change in Accounts Payable | 38.47 | -90.59 | 70.36 | 39.21 | 55.25 | Upgrade
|
| Change in Other Net Operating Assets | -133.25 | 141.87 | 11.4 | 0.1 | -2.96 | Upgrade
|
| Operating Cash Flow | -9.82 | 2.76 | -45.17 | -61.78 | -61.63 | Upgrade
|
| Capital Expenditures | -2.44 | -8.19 | -4.02 | -22.92 | -32.58 | Upgrade
|
| Sale (Purchase) of Intangibles | -1.63 | -5.87 | -13.76 | -14.83 | -21.88 | Upgrade
|
| Investment in Securities | - | -1.62 | - | -0.19 | -5.6 | Upgrade
|
| Other Investing Activities | -0 | 0.69 | - | - | - | Upgrade
|
| Investing Cash Flow | -4.07 | -14.99 | -17.78 | -37.94 | -60.06 | Upgrade
|
| Long-Term Debt Issued | 44.5 | 28.35 | - | 1.09 | 39.02 | Upgrade
|
| Long-Term Debt Repaid | -12.94 | -14.18 | -15.05 | -14.89 | -70.64 | Upgrade
|
| Net Debt Issued (Repaid) | 31.56 | 14.17 | -15.05 | -13.8 | -31.62 | Upgrade
|
| Issuance of Common Stock | - | - | 70.78 | - | 245.65 | Upgrade
|
| Other Financing Activities | -15.98 | -10.48 | -10.28 | -9.39 | -14.06 | Upgrade
|
| Financing Cash Flow | 15.58 | 3.69 | 45.45 | -23.2 | 199.97 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | 0 | - | - | 0 | - | Upgrade
|
| Net Cash Flow | 1.69 | -8.54 | -17.49 | -122.91 | 78.28 | Upgrade
|
| Free Cash Flow | -12.26 | -5.43 | -49.19 | -84.7 | -94.21 | Upgrade
|
| Free Cash Flow Margin | -4.62% | -2.49% | -40.84% | -96.68% | -136.04% | Upgrade
|
| Free Cash Flow Per Share | -0.03 | -0.01 | -0.13 | -0.24 | -0.28 | Upgrade
|
| Cash Interest Paid | 15.69 | 9.49 | 9.95 | 9.39 | 8.58 | Upgrade
|
| Levered Free Cash Flow | 21.85 | -100.88 | -72.21 | -65.15 | -94.57 | Upgrade
|
| Unlevered Free Cash Flow | 31.66 | -96.16 | -65.99 | -59.28 | -88.81 | Upgrade
|
| Change in Net Working Capital | -61.62 | 54.44 | 0.51 | -20.13 | 3.61 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.